profit from every $100 of sales.
$0$100
Modular Medical
$1.67-9.73% today
-89.1% in 1 year
1-year low $1.281-year high $16.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Modular Medical sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$18.8 million of profit last year.
SalesProfit
Modular Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Modular Medical | No profit yet | ||
 Boston Scientific | 22.4× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.9× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads Modular Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -15 | -14 | -18 | -19 | |
| -16 | -14 | -17 | -18 | |
| -19 | -14 | -17 | -19 | |
| -82.20 | -34.50 | -23.40 | -15.30 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 10 | 7 | 14 | 19 |
| Cash | 9 | 4 | 9 | 13 |
| Total debt | 0 | 2 | 1 | 1 |
| Total liabilities | 1 | 2 | 2 | 2 |
| 9 | 5 | 12 | 17 | |
| 0 | 0 | 1 | 1 | |
| -139.0% | -165.6% | -108.8% | -84.1% | |
| -210.9% | -273.4% | -151.5% | -110.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -10 | -11 | -14 | -16 | |
| 0 | 2 | 2 | 2 | |
| -10 | -13 | -16 | -18 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 4 | 3 | 3 | 2 |
Valuation
- –
- –
- –
- 1.9×
- –
- –
- –
- -114.9%
- -118.7%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -314.3%
- -227.7%
- -245.8%
- -261.0%
- -332.4%
- –
Growth
- –
- –
- −16.4%
- –
- +56.2%
Financial health
- 0.1×
- 0.09
- 4.9%
- –
- 1.59
- 1.59
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 21%of 877
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 17, 2026 | -3.30 | -3.00 | −10.0% |
| Nov 14, 2025 | -0.14 | -0.10 | −40.0% |
| Aug 14, 2025 | -0.12 | -0.10 | −20.0% |
| Jun 20, 2025 | -0.12 | -0.11 | −9.1% |
| Feb 13, 2025 | -0.13 | -0.12 | −8.3% |
| Nov 14, 2024 | -0.14 | -0.14 | +0.0% |
| Aug 13, 2024 | -0.12 | -0.12 | +0.0% |
| Jun 21, 2024 | -0.14 | -0.20 | +30.0% |
News
NuScale Power Trades Below $6 With the Only NRC-Certified Small Modular Reactor Design. Here's Why That Still Isn't Enough.Yahoo Finance · Oct 25, 2026Crusoe Announces Support for NVIDIA DSX POD, Bringing Field-Proven Crusoe Spark™ Platform to the Expanding Modular EcosystemYahoo Finance · Oct 21, 2026NuScale Power Is Closing In on a Deal That Could Transform the Small Modular Reactor IndustryYahoo Finance · Sep 15, 2026Assessment of the U.S. Nuclear Power and Small Modular Reactor Market 2026 Now Available — Reveals Why Big Tech Is Becoming an Active Force in Nuclear Project Formation, Not Just a Power BuyerYahoo Finance · Sep 3, 2026What Is a Small Modular Reactor, and Why Is Big Tech Signing Multi-Decade Deals for Them?Yahoo Finance · Sep 1, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/6Passes 0 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
31No pass
Benjamin Graham
46No pass
Philip Fisher
34No pass
Peter Lynch
59No pass
Joel Greenblatt
–Not enough data
Charlie Munger
28No pass
Terry Smith
28No pass
Questions about Modular Medical
Is Modular Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Modular Medical AI analysis
What does Modular Medical do?
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California. It is in Medical - Devices.
Does Modular Medical pay a dividend?
No. Modular Medical does not pay a dividend at the moment.
Is Modular Medical stock halal?
No. Modular Medical does not pass our halal screen: its cash and confirmed interest-bearing investments are 83% of its market value, at or above the 33% limit. How we check
How has Modular Medical stock done over the past year?
Down 89.1% over the past twelve months, to $1.67. It traded between $1.28 and $16.00 and is 89.6% below its high.
Who are Modular Medical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Modular Medical's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.